Finding new biomarkers and tools for Mucopolysaccharidosis IIIC patients.
Identification of Potential Biomarkers and Clinical Tools for use in Mucopolysaccharidosis IIIC Patients.
This study is looking for ways to better diagnose and manage Mucopolysaccharidosis Type IIIC, a rare condition, by finding helpful markers in the body and improving how we track the disease, so patients can get better care and support.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Phoenix Nest, INC. NIH-funded |
| Lab location | 1 site (Brooklyn, United States) |
| Project ID | NIH-10921133 on NIH RePORTER |
What this research studies
This research focuses on identifying potential biomarkers and clinical tools that could help in the diagnosis and management of Mucopolysaccharidosis Type IIIC (MPS IIIC), a rare lysosomal storage disease. The study aims to understand the underlying biochemical processes and develop methods to assess the condition more effectively. By analyzing biological samples and patient data, the research seeks to improve early detection and monitoring of disease progression. This could lead to better supportive care and potentially pave the way for future therapeutic options.
Who could benefit from this research
Good fit: Ideal candidates for this research are children diagnosed with Mucopolysaccharidosis Type IIIC, particularly those under the age of 15.
Not a fit: Patients with other types of lysosomal storage diseases or those over the age of 15 may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved diagnosis and management strategies for patients with MPS IIIC, enhancing their quality of life.
How similar studies have performed: While research into biomarkers for lysosomal storage diseases is ongoing, this specific approach for MPS IIIC is relatively novel and has not been extensively tested.
Where this research is happening
Brooklyn, United States
- Phoenix Nest, INC. — Brooklyn, United States (Active)
Researchers
- Principal investigator: Singamsetty, Srikanth — Phoenix Nest, INC.
- Study coordinator: Singamsetty, Srikanth
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.